Reaction Details Report a problem with these data
Target
N-formyl peptide receptor 2
Ligand
BDBM37603
Substrate
n/a
Meas. Tech.
Dose Response Assay for Formylpeptide Receptor-Like-1 (FPRL1) Ligands and Dose Response Counter-Screen Assay for Formylpeptide Receptor (FPR) Ligands
IC50
>66700±n/a nM
Comments
Extracted from aid = 520 and tid = 3
Citation
 PubChem, PC Dose Response Assay for Formylpeptide Receptor-Like-1 (FPRL1) Ligands and Dose Response Counter-Screen Assay for Formylpeptide Receptor (FPR) Ligands PubChem Bioassay (2007)[AID] 
Target
Name:
N-formyl peptide receptor 2
Synonyms:
ALXR, FPRL1, FPR2 | FMLP-related receptor I FMLP-R-I | FPR2 | FPR2_HUMAN | FPRH1 | FPRL1 | Formyl Peptide Receptor-Like 1 | HM63 | LXA4 receptor | LXA4R | Lipoxin A4 receptor | Lipoxin A4 receptor (LXA4) | RFP | hFPRL
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
38968.35
Organism:
Homo sapiens (Human)
Description:
P25090
Residue:
351
Sequence:
METNFSTPLNEYEEVSYESAGYTVLRILPLVVLGVTFVLGVLGNGLVIWVAGFRMTRTVTTICYLNLALADFSFTATLPFLIVSMAMGEKWPFGWFLCKLIHIVVDINLFGSVFLIGFIALDRCICVLHPVWAQNHRTVSLAMKVIVGPWILALVLTLPVFLFLTTVTIPNGDTYCTFNFASWGGTPEERLKVAITMLTARGIIRFVIGFSLPMSIVAICYGLIAAKIHKKGMIKSSRPLRVLTAVVASFFICWFPFQLVALLGTVWLKEMLFYGKYKIIDILVNPTSSLAFFNSCLNPMLYVFVGQDFRERLIHSLPTSLERALSEDSAPTNDTAANSASPPAETELQAM
  
Inhibitor
Name:
BDBM37603
Synonyms:
(5Z)-5-(1-ethyl-2-keto-indolin-3-ylidene)-3-(3-methoxypropyl)-2-thioxo-thiazolidin-4-one | (5Z)-5-(1-ethyl-2-oxidanylidene-indol-3-ylidene)-3-(3-methoxypropyl)-2-sulfanylidene-1,3-thiazolidin-4-one | (5Z)-5-(1-ethyl-2-oxo-3-indolylidene)-3-(3-methoxypropyl)-2-sulfanylidene-4-thiazolidinone | (5Z)-5-(1-ethyl-2-oxoindol-3-ylidene)-3-(3-methoxypropyl)-2-sulfanylidene-1,3-thiazolidin-4-one | 1-Ethyl-3-[3-(3-methoxy-propyl)-4-oxo-2-thioxo-thiazolidin-(5Z)-ylidene]-1,3-dihydro-indol-2-one | MLS000071796 | SMR000009360 | cid_1960010
Type:
Small organic molecule
Emp. Form.:
C17H18N2O3S2
Mol. Mass.:
362.466
SMILES:
CCN1C(=O)\C(=C2/SC(=S)N(CCCOC)C2=O)c2ccccc12
Structure:
Search PDB for entries with ligand similarity: